ACM vs J: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

J is the larger of the two ($18.44B market cap): the incumbent the market prices for continued execution (18.96x forward earnings, beta 0.67). ACM is the smaller challenger ($9.04B), cheaper on forward earnings (11.25x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.

ACM vs J: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricACMJWhat it tells you
Market cap$9.04B$18.44BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E11.2518.96Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E24.7251.88Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Beta0.900.67Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range17% of range90% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book4.125.60How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Reading it: ACM is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how ACM and J affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ACM and J share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ACM and J exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does AECOM (ACM) do?

AECOM is in the business of engineering expertise, not steel. The company plans, designs, engineers and manages infrastructure programs for governments and large corporations: highways and transit systems, water and wastewater treatment, airports and ports, environmental remediation, flood defenses, and increasingly the power and site work behind data centers. It reports in three segments, Americas (about $2.9 billion of quarterly revenue), International (about $890 million), and a small AECOM Capital investment arm, and employs roughly 51,000 people. Critically, AECOM exited self-perform construction years ago, so it no longer takes fixed-price building risk on its own balance sheet. What is left is a professional services business with very little capital intensity, which is why return on equity has historically run high on about $3.33 billion of debt against $1.02 billion of cash (June 30, 2026).

Full ACM guide

What does Jacobs Solutions Inc. (J) do?

Jacobs Solutions Inc. (NYSE: J) is a Dallas-based professional services firm of roughly ~47,000 people that designs, plans and manages large physical assets: water and wastewater systems, highways and transit, semiconductor fabs, pharmaceutical plants, power and grid infrastructure, and increasingly data centers. It reports in two segments. Infrastructure & Advanced Facilities is the bulk of it, generating ~$3.75 billion of gross revenue in the June 2026 quarter, of which ~$2.09 billion was adjusted net revenue after stripping pass-through costs, at a segment operating margin near ~12.8%. PA Consulting, the UK-based strategy and innovation consultancy, is much smaller at ~$330 million of quarterly revenue but far richer, running near ~22% segment operating margin. Jacobs completed the purchase of the remaining PA Consulting shares on March 20, 2026 for aggregate initial consideration of about ~£1.21 billion, taking ownership from roughly 71% to full.

Full J guide

ACM vs J: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • ACM drivers: A record backlog that is growing faster than revenue; Margin expansion in an asset-light model.
  • J drivers: Backlog is growing faster than revenue; The AI build-out has reached the engineering layer.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: The cash flow problem remains live and has been joined by an earnings problem: the fiscal third quarter of 2026 included a one-off charge on a legacy project that produced a ~$87 million net loss and a guidance cut. For J, the headline growth rate is flattered by pass-through revenue, which nearly doubled the gap between gross and net revenue growth in the June quarter, so a mix shift toward construction-heavy work can inflate revenue while adding nothing to profit.

ACM or J: which should you pick?

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ACM if you believe its drivers more; J if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ACM and J guides.

ACM vs J: the full fundamentals

ACM. At ~$59 on October 16, 2026, AECOM trades near 9.3 times consensus fiscal 2027 EPS of ~$6.36, a lower multiple than in August, because the market now doubts both cash conversion and near-term earnings after the third-quarter charge and guidance cut. Trailing GAAP figures are weak (net income of ~$373 million on ~$15.4 billion of revenue, a trailing P/E near 21), so the forward and trailing multiples tell very different stories. Analysts' mean target of ~$84 across 12 firms sits well above the share price, which shows how wide the disagreement has become.

J. At ~$141 a share on October 16, 2026 the market capitalization is roughly ~$16.7 billion, about ~17 times fiscal 2027 consensus EPS of ~$8.25 and near ~47 times trailing GAAP EPS. That spread reflects ~$402.9 million of restructuring and transaction charges booked in the first nine months of fiscal 2026, ~$105.5 million of intangible amortization and a temporarily elevated tax rate from the PA Consulting purchase, so the fiscal fourth-quarter report expected around November 19 and its first fiscal 2027 guide decide which multiple the market leans on. Enterprise value runs near ~18 times trailing EBITDA.

Headline figures (approximate, October 2026): ACM shows revenue (ttm) ~$15.4 billion (fiscal Q3 2026 down ~14% yoy), fiscal q3 2026 eps ~-$0.50 vs ~$1.46 consensus (legacy-project charge), net income (ttm) ~$373 million (~1.9% margin), p/e (trailing / forward) ~20.8x / ~9.3x; J shows revenue (ttm, gross) ~$14.2B, up ~34.5% y/y in the June quarter, adjusted net revenue (9m fy2026) ~$7.0B, FY guide ~9.5% to 10% growth, adjusted eps (fy2026 guidance) ~$7.20 to ~$7.30; consensus ~$7.27, FY2027 consensus ~$8.25, gaap eps / net income (ttm) ~$3.01 / ~$359M, a ~2.4% net margin.

The bottom line: ACM vs J

ACM and J are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ACM and J exposure against your real portfolio. It is not an investment adviser.

Wondering how ACM or J fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about AECOM

Ask Walnut's AI anything about ACM and see how it fits what you own.

FAQ

What is the difference between ACM and J?

+

AECOM is in the business of engineering expertise, not steel. Jacobs Solutions Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is ACM or J the better stock?

+

Neither is universally better. J is the larger incumbent; ACM is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, ACM or J?

+

On forward P/E (as of November 2026), ACM trades at 11.25x and J at 18.96x, so ACM is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both ACM and J?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of ACM vs J?

+

ACM: The cash flow problem remains live and has been joined by an earnings problem: the fiscal third quarter of 2026 included a one-off charge on a legacy project that produced a ~$87 million net loss and a guidance cut. Earlier, operating cash flow fell 98% in the fiscal second quarter of 2026 and free cash flow went negative, while significant claims recorded in contract assets and other non-current assets grew to roughly $680 million from about $400 million at the September 2025 fiscal year end. Full-year free cash flow guidance of roughly $400 million therefore depends on collecting a large amount in the back half, and if claims resolution keeps slipping, the reported earnings growth will look increasingly disconnected from cash. Several plaintiffs' firms (Pomerantz, Glancy Prongay, Schall, Howard G. Smith, Frank R. Cruz) announced securities-fraud investigations in May and June 2026 over the disclosures around that quarter; these were described as investigations rather than a filed class action as of August 2026, and their status should be re-checked after the third-quarter charge. Government client concentration cuts both ways, exposing the company to budget cycles, appropriations delays and procurement slowdowns, and International net service revenue was already declining 3% in constant currency. Several brokers cut price targets in October 2026 (Truist to $75 from $85, UBS to $103 from $106, RBC to $89 from $90), and fiscal fourth quarter results on November 17, 2026 are the next catalyst in either direction. J: The headline growth rate is flattered by pass-through revenue, which nearly doubled the gap between gross and net revenue growth in the June quarter, so a mix shift toward construction-heavy work can inflate revenue while adding nothing to profit. Concentration in data center and semiconductor projects cuts both ways: a pause in hyperscaler or fab capital budgets would show up in bookings well before it showed up in revenue, and those clients can defer projects far faster than a state transportation department can. Public infrastructure work carries its own exposure to changes in Infrastructure Investment and Jobs Act funding levels and to federal spending priorities. Jacobs is also a party to the Consolidated JV Matter, an unfavorable interim ruling against a joint venture in which it holds a 50% interest, which drove reserves in fiscal 2025 and remains an open item. Valuation leaves less room for error than it did: the stock trades near ~47 times trailing GAAP earnings and ~18 times EV to EBITDA, and total debt is about ~$4.05 billion against ~$1.18 billion of cash after the PA buyout. Expectations for the November 19 report sit at ~$2.12 of adjusted EPS, ~21% growth, so a miss or a soft fiscal 2027 outlook would land on a stock already down ~10% over the past year. No securities-fraud class action was disclosed in the August 2026 quarterly filing, and the litigation described there is the ordinary professional liability, personal injury and contract mix for a firm of this size.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell ACM or J; figures are approximate and dated (as of November 2026). Verify current data before investing.